Success Metrics

Clinical Success Rate
90.6%

Based on 48 completed trials

Completion Rate
91%(48/53)
Active Trials
9(11%)
Results Posted
25%(12 trials)
Terminated
5(6%)

Phase Distribution

Ph phase_4
3
4%
Ph not_applicable
38
46%
Ph phase_1
3
4%
Ph early_phase_1
1
1%
Ph phase_3
1
1%
Ph phase_2
1
1%

Phase Distribution

4

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution47 total trials
Early Phase 1First-in-human
1(2.1%)
Phase 1Safety & dosage
3(6.4%)
Phase 2Efficacy & side effects
1(2.1%)
Phase 3Large-scale testing
1(2.1%)
Phase 4Post-market surveillance
3(6.4%)
N/ANon-phased studies
38(80.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.2%

48 of 57 finished

Non-Completion Rate

15.8%

9 ended early

Currently Active

9

trials recruiting

Total Trials

82

all time

Status Distribution
Active(13)
Completed(48)
Terminated(9)
Other(12)

Detailed Status

Completed48
unknown12
Recruiting7
Terminated5
Withdrawn4
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
82
Active
9
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.1%)
Phase 13 (6.4%)
Phase 21 (2.1%)
Phase 31 (2.1%)
Phase 43 (6.4%)
N/A38 (80.9%)

Trials by Status

active_not_recruiting22%
enrolling_by_invitation11%
not_yet_recruiting34%
recruiting79%
completed4859%
unknown1215%
terminated56%
withdrawn45%

Recent Activity

Clinical Trials (82)

Showing 20 of 82 trialsScroll for more
NCT01762046Phase 1

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

Completed
NCT04451980

The HIV, Adipose Tissue Immunology, and Metabolism Study

Completed
NCT00921609

Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly

Completed
NCT04958109Phase 1

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test

Completed
NCT06813014Phase 4

Pharmacogenetics of Response to Sitagliptin (PRS)

Not Yet Recruiting
NCT07410637Not Applicable

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Recruiting
NCT07366710Not Applicable

Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

Active Not Recruiting
NCT06184373

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Recruiting
NCT02383316Not Applicable

Study of Metabolic Modifications in Children With Noonan Syndrome

Completed
NCT06876090

Sarcopenia in Gestational Diabetes

Recruiting
NCT05998772

Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease

Recruiting
NCT04364087

Glucose Metabolism and Live Birth Outcomes in PCOS

Completed
NCT05328570Not Applicable

Comparing the Effects of Exercise on the Structure and Function of Fat Tissue

Completed
NCT01692002Not Applicable

Oral Propionate to Treat and Prevent Diabetes

Terminated
NCT04063098Not Applicable

Glucose-homeostasis After Endoscopic Sleeve Gastroplasty

Completed
NCT06942312

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Enrolling By Invitation
NCT04034706

Transcriptional and Epigenetic Program of PCOS Women

Active Not Recruiting
NCT05568134

Alternate Measures of Glucose During OGTT Testing for CFRD

Completed
NCT05058690Not Applicable

Artificial Intelligence to Improve Cardiometabolic Risk Evaluation Using CT Scans

Not Yet Recruiting
NCT03650712Not Applicable

EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

Completed

Drug Details

Intervention Type
OTHER
Total Trials
82